关于维适平®(精氨酸艾曲莫德片,VELSIPITY®)维适平®是一种每日一次口服的高选择性鞘氨醇-1-磷酸(S1P)受体调节剂,采用优化的药理学设计,与S1P受体1、4和5结合。维适平®目前已在美国、欧盟、加拿大、日本、澳大利亚、英国、瑞士、以色列、土耳其、印度以及中国澳门、新加坡、中国香港和中国大陆获得新药上市批准。关于云顶新耀云顶新耀是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司...
Source Link关于维适平®(精氨酸艾曲莫德片,VELSIPITY®)维适平®是一种每日一次口服的高选择性鞘氨醇-1-磷酸(S1P)受体调节剂,采用优化的药理学设计,与S1P受体1、4和5结合。维适平®目前已在美国、欧盟、加拿大、日本、澳大利亚、英国、瑞士、以色列、土耳其、印度以及中国澳门、新加坡、中国香港和中国大陆获得新药上市批准。关于云顶新耀云顶新耀是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.